Back to INBX
Bank of New York Mellon Corp → INBX
Bank of New York Mellon Corp INBX Position History
Inhibrx Biosciences, Inc. • Healthcare
Quarters held
14
Latest value
$100
Q3 2026
Peak value
$1.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $797K |
| Q4 2025 | $1.3M |
| Q4 2025 | $7K |
| Q1 2026 | $678K |
| Q1 2026 | $1.1M |
| Q1 2026 | $6K |
| Q2 2026 | $832K |
| Q2 2026 | $1.6M |
| Q2 2026 | $8K |
| Q2 2026 | $95 |
| Q3 2026 | $759K |
| Q3 2026 | $1.8M |
| Q3 2026 | $8K |
| Q3 2026 | $100 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $100 | 1 | — | — |
| Q3 2026 | $8K | 83 | — | — |
| Q3 2026 | $1.8M | 18.5K | — | — |
| Q3 2026 | $759K | 7.6K | — | — |
| Q2 2026 | $95 | 1 | — | — |
| Q2 2026 | $8K | 83 | — | — |
| Q2 2026 | $1.6M | 17.3K | — | — |
| Q2 2026 | $832K | 8.8K | — | — |
| Q1 2026 | $6K | 83 | — | — |
| Q1 2026 | $1.1M | 15.7K | — | — |
| Q1 2026 | $678K | 10.1K | — | — |
| Q4 2025 | $7K | 83 | — | — |
| Q4 2025 | $1.3M | 16.6K | — | — |
| Q4 2025 | $797K | 10.1K | — | — |
Other funds holding INBX
$271.7M
$172.4M
$131.2M
$129.3M
$126.4M
$125.3M